Insulin resistance is commonly associated with obesity and noninsulin-dependent diabetes. Whereas it predicts the development of diabetes, its effect on body weight change is unknown. We measured glucose disposal rates at submaximally-and maximally-stimulating insulin concentrations in 192 nondiabetic Pima Indians and followed their weight change over 3.5±1.8 y (mean±SD).
Introduction
Decreased insulin-mediated glucose disposal (insulin resistance) is found in virtually all patients with noninsulin-dependent diabetes mellitus (NIDDM)' (1, 2) , and is a significant predictor of the disease in Pima Indians (3) . Insulin resistance is also commonly associated with obesity, and probably represents the mechanism by which obesity exerts its influence on the development of NIDDM. However, the relationship, if any, of insulin resistance to change in weight is not known.
The Pima Indians of Arizona are very prone to NIDDM and obesity (4) and are insulin-resistant compared to Caucasians of the same body mass index (5) . It is possible that insulin resistance could accelerate body weight gain, thereby predisposing to obesity as well as NIDDM. Indeed, it has been previously suggested that insulin resistance, or the consequent hyperinsulinemia, may cause obesity via inhibition oflipolysis (6) , reduced thermic effect offood (7) , or increased appetite (8) . This would imply a positive feedback relationship, whereby insulin resistance induced by weight gain would tend to increase further weight gain.
On the other hand, there is evidence in Pima Indians that a low rate ofglucose to lipid oxidation (low respiratory quotient)
is associated with a reduced rate of weight gain (9) . Because a low rate ofglucose oxidation contributes to a low overall rate of glucose disposal (oxidation plus storage), insulin resistance may also be associated with a reduced rate of weight gain.
To further examine this issue, we measured the glucose disposal rates in 192 nondiabetic Pima Indians and followed their weight change over a mean period of 3.5 yr. We found that insulin-resistant subjects gained less weight than insulinsensitive subjects.
Methods
Subjects. The subjects were Pima Indians living in the Gila River Indian Community in Arizona. They were participating in a longitudinal study of the development of NIDDM and obesity which included annual admissions to a metabolic research ward. Subjects were in good health as assessed by medical history, physical examination, and routine tests. All subjects gave informed consent and the studies were approved by the ethics committees of the National Institutes of Health, the Indian Health Service, and the Tribal Council of the Gila River Indian Community. During each 8-16-d admission to the metabolic ward, subjects were fed a weight-maintenance diet (50% of calories as carbohydrate, 30% as fat, and 20% as protein). Body composition was estimated by underwater weighing (10, 11) . Body fat distribution was assessed by the waist:thigh circumference ratio. A minimum of2 d after admission, all subjects underwent a 75-g oral glucose tolerance test. Ifa diagnosis of diabetes was made according to National Diabetes Data Group criteria (12), data from that and subsequent admissions were excluded from the analysis for that subject. This was done to avoid any bias that weight loss from glycosuria or therapeutic diets may have on the results. 195 subjects had at least one follow-up admission 6 mo or more after the initial admission. Three subjects were deleted as outliers: one subject had an intentional weight loss of 12.5% in 1 yr, and two had very large weight gains (41 and 48 kg), each of these values being > 4 SD from the respective group mean. Therefore, 192 subjects who had a total of 673 follow-up admissions were used for the analyses. Weight change between the first and the last admission was used for all analyses except the survival analysis in which each admission was considered separately. Of the 192 subjects, 109 also had 24-h energy expenditure measured in a respiratory chamber during admission, and these results were adjusted for individual differences in fat-free mass, fat mass, age, and sex as previously described (13) . Euglycemic clamp data from the last admission were available in 124 of the subjects.
Hyperinsulinemic, euglycemic clamp. After 8-15 d, a two-step hyperinsulinemic, euglycemic clamp was performed by a modification of the method ofDeFronzo et al. (14) as previously described (15) . Briefly, 3-3H-glucose was infused for 220 min and hepatic glucose production was estimated at 100-120 min and at 200-220 min (16) . Insulin, at a low dose (40 mU/[body surface area in square meters] per minute), was infused from 120-220 min, then at a high dose (400 mU/m2 per min) from 220-320 min while euglycemia was maintained with a variable infusion of 20% dextrose. During the last 40 min of the low-dose and high-dose infusions, the mean (±SD) insulin concentrations were 910±265 pM (mean coefficient of variation [CV.] = 5.7±5.6%) and 14,420±3,760 pM (C.V. = 7.1±11.7%), respectively, and the mean glucose concentrations were 5.2±0.3 mM (C.V. = 2.3± 1.0%) and 5.2±0.3 mM (C.V. = 2.8±1.1%), respectively. Insulin-mediated glucose disposal at submaximally-(SubmaxM) and maximally-stimulating (MaxM) insulin concentrations were calculated from the 40-min periods as described (14, 15).
To account for differences in metabolic size among subjects, glucose disposal rates were divided by estimated metabolic body size (EMBS; fat-free body mass + 17.7 kg) as described elsewhere (17) Fig. 1 (r = -0.38, P < 0.0001). We examined the subsequent weight change in those subjects above the regression line (i.e., insulin-sensitive for their body weight) and those below the regression line (i.e., insulin-resistant for their body weight) (Table III). The insulin-resistant subjects were older, had higher insulin concentrations before and during the oral glucose tolerance test, and had less than half the weight gain of the insulinsensitive subjects (3.1 vs. 7.6 kg, P < 0.0001). During the study, three subjects (one male, two females) of the insulin-sensitive group and 13 subjects (four males, nine females) ofthe insulinresistant group developed NIDDM. There was a significant correlation between the residual values (deviation from the re- Values are means±SEM with ranges in parentheses. * P < 0.001 males vs. females. $ P < 0.05 males vs. females. gression line) and the percent weight change per year (r = 0.36, P < 0.0001). The correlations were similar if the relationships were calculated for males only (r = 0.39, P < 0.0001) or females only (r = 0.38, P < 0.001).
Correlations between glucose disposal and weight change. The absolute weight change (kilograms) over the study period was significantly correlated with initial weight (r = 0.18, P < 0.05) and length offollow-up (r = 0.20, P < 0.01). Therefore, to minimize the effects of varying durations of follow-up and different initial body weights, we expressed weight change as a percentage weight change per year (which was not correlated with initial weight) for the remainder of the correlation analyses. This rate of percent weight change was significantly correlated with SubmaxM (Table IV, r = 0. 19, P < 0.01) and MaxM (Table IV and Fig. 2 , r = 0.34, P < 0.0001). The change in weight was more closely related to glucose oxidation than to glucose storage (Table IV) , despite the fact that total glucose disposal is more highly correlated with glucose storage (r = 0.83, P < 0.0001 for SubmaxM; r = 0.95, P < 0.0001 for MaxM) than with glucose oxidation (r = 0.59, P < 0.0001 for SubmaxM; r = 0.60, P < 0.0001 for MaxM).
The weight change also correlated with age (r = -0.22, P Body Wih (kg) Figure 1 . Correlation between glucose disposal at maximum-stimulating insulin concentrations (MaxM) and initial body weight in 104 male (A) and 88 female (-) nondiabetic Pima Indians (r = -0.38, P < 0.0001, ,B = -0.03 mg/kgEMBS* min per kg). Subjects above the regression line (n = 95) gained (mean) 7.6 kg and those below the line (n = 97) gained 3.1 kg (P < 0.0001) over 3.5 yr. EMBS = fat-free mass + 17.7 kg (17). 24 observations hidden. < 0.01), total area under the insulin curve during an oral glucose tolerance test (r = -0.21, P < 0.01), but was not correlated with the glucose area under the curve (r = -0.1 1, NS), fasting insulin (r = -0.1 1, NS), fasting glucose (r = -0.05, NS), or waist:thigh ratio (r = -0.14, NS). When these variables were analyzed in multiple linear regression models with either SubmaxM or MaxM, the predictors of weight gain were higher SubmaxM (P < 0.05), younger age (P < 0.05), and female sex (P < 0.05) in one model (r2 = 0.09, P < 0.001), and higher MaxM (P < 0.0001), younger age (P = 0.08), and female sex (P < 0.05) in the other (r2 = 0.15, P < 0.0001). The group was divided into "less obese" and "more obese" according to the mean initial weight for each sex. The effect of SubmaxM and MaxM on weight change was stronger in the less obese group (P < 0.05, P < 0.0001) than in the more obese group (P = NS, P < 0.02). In the subgroup of 109 subjects in whom data from the respiratory chamber were available, the effect of SubmaxM (P < 0.05) and MaxM (P < 0.05) on the percent weight change per year was independent of age, sex, and the 24-h energy expenditure adjusted for fat-free mass, fat mass, age, and sex.
When the correlation analyses were checked for possible biases (see Methods for details), the relationships between SubmaxM and MaxM and the rate of weight change were maintained. (a) Inclusion of 16 subjects after the diagnosis of diabetes (r = 0.22, P < 0.01; r = 0.33, P < 0.0001, respectively, for SubmaxM and MaxM, n = 192). (b) Only normal glucose tolerant subjects used (r = 0.22, P < 0.05; r = 0.36, P < 0.0001, n = 126). (c) Mean, rather than initial, values for SubmaxM and MaxM used (r = 0.18, P < 0.05; r = 0.23, P < 0.05, n = 124). (d) Follow-up periods of < 2 yr excluded (r = 0.19, P < 0.05; r -0.38, P < 0.0001, n = 144).
Survival analysis of weight gain. Survival analysis (using the proportional hazards model) examines the cumulative incidence of reaching a predefined "failure" point. We defined three "failure" points: 5 kg, reached by 107 subjects; 10 kg reached by 58 subjects; and 15 kg reached by 30 subjects.
MaxM was a significant predictor of weight change (independent of initial weight, age, and sex) at 5 kg (P < 0.01), 10 kg (P < 0.01), and 15 kg (P < 0.01), whereas SubmaxM was significant at 10 kg (P < 0.05), borderline at 15 kg (P = 0.05), but not at 5 kg (P = 0. 12). The hazard rate ratios for "failure" at 10 kg between the 90th percentile (SubmaxM = 4.1, MaxM = 11.5 Fig. 3 with the middle group representing the overall group mean. Change in weight and change in insulin sensitivity. 124 subjects had a euglycemic clamp during their final admission (mean insulin concentrations±SD were 1,008±337 for SubmaxM and 16,900±4,650 pM for MaxM). The relationship between the change in weight (kilograms) and the changes in insulin action were r = -0.40 (P < 0.0001) for SubmaxM and r = -0.52 (P < 0.0001) for MaxM (Fig. 4) . When one subject (indicated by asterisk in the figure) was deleted as an outlier, the latter relationship was stronger (r = -0.57, P < 0.0001, n = 123). The slope ofthe relationship (in mg/kgEMBS -min per kg body wt) between change in weight and change in MaxM was steeper (,6 = -0.134, n = 124) than that of the cross-sectional relationship ofweight and MaxM (# = -0.030, n = 192).
Discussion
This group of 192 nondiabetic Pima Indians gained a significant amount of weight over 3.5 yr of follow-up, but the more insulin-resistant subjects gained the least. Insulin resistance, whether or not it was corrected for the initial body weight, was associated with a lower rate ofweight gain than insulin sensitiv- ity. This relationship was independent of age, sex, and 24-h energy expenditure. These findings are contrary to the hypothesis suggesting that insulin resistance, or its consequent hyperinsulinemia, predisposes to obesity. Based on in vivo and in vitro fat cell studies, Arner (6) postulated that the hyperinsulinemia ofinsulin resistance would suppress insulin-sensitive lipolysis in the adipocyte, thereby leading to further fat accumulation. Felig (7) hypothesized that resistance to the insulin-mediated component of the thermogenic effect of food could lead to weight gain. However, this component is only a small fraction of the total 24-h energy expenditure, and there is even considerable controversy about whether such a defect exists in insulin-resistant individuals (23) . The effect of insulin on hunger and food intake has attracted considerable research, largely in animals, over the last 30 years (24) . Some investigators have found that insulin stimulates food intake (8, 25) , whereas others have found insulin suppresses it (26) .
The current study examines the effect of insulin resistance on weight change in a longitudinal manner in humans. The Pima Indians are an obese population, and the vast majority of the subjects in this study gained weight. Whether this effect of insulin resistance on weight change will be seen in more weight-stable populations is not known. The reliability of the tracer technique employed in this study to determine hepatic glucose production has been questioned (27) . Errors in the estimation of hepatic glucose production during the low-dose infusion will add to the imprecision of SubmaxM as a measurement. MaxM, on the other hand, is measured at a supraphysiological insulin concentration which completely suppresses hepatic glucose production making it a more accurate measurement. This may explain why MaxM was more powerful than SubmaxM at predicting weight change in almost all analyses.
Insulin resistance is the third metabolic predictor of weight change to be described in this population, the other two being resting metabolic rate (28) and respiratory quotient (9) (28) and decreased respiratory quotient (9) associated with weight gain. This suggests the possibility of a negative feedback relationship whereby an increase in weight causes a somewhat exaggerated increase in insulin resistance which in turn serves to slow down the rate of weight gain.
This proposed interaction helps to explain some ofthe findings in this study which may appear contradictory. If weight gain causes insulin resistance, how can some individuals who are clearly overweight be quite insulin sensitive? It may be that those overweight individuals experienced some weight loss before their first admission, and this resulted in them being somewhat more insulin sensitive for their weight at the beginning of the study. During the follow-up period, they had a much higher chance of gaining weight than those who perhaps experienced some weight gain (and "exaggerated" insulin resistance) before the first admission.
Also, if the insulin resistance induced by weight gain does attenuate further weight gain, how can the presence of such an obese, yet insulin-resistant population like the Pimas (5) be explained? Although we have shown that insulin sensitivity predicts weight gain, clearly it cannot be the major driving force for the widespread gross obesity in the population because of its apparent negative feedback relationship with weight gain. However, in the presence of some major energy imbalance (such as a hypercaloric diet, decreased physical activity), we would speculate that the degree ofinsulin resistance or insulin sensitivity may have a modulating effect on body weight, thereby limiting the impact of large changes in energy balance on body weight. This modulating effect may be weaker in the more obese subjects who are closer to the lower physological limits of insulin sensitivity.
By what mechanisms might insulin resistance limit weight gain? Glucose oxidation was a stronger predictor of weight change than was glucose storage or insulinemia. This implies that the mechanisms may involve the control ofglucose oxidation, and this is supported by the finding that a low 24-h respiratory quotient (an independent measurement of a low glucose oxidation relative to lipid oxidation) is associated with a slower rate ofweight gain (9) . Because glucose and lipid oxidation are closely reciprocally related, it may be the control oflipid oxidation which is important and the glucose oxidation rates are simply reciprocal reflections (29) . However, this is less likely because glucose oxidation seems to take priority over lipid oxidation, especially during and after meals (30) . Mechanisms which lower glucose oxidation would have two important effects on energy balance: (a) the reciprocal increase in fat oxidation needed to meet energy demands would limit fat storage; (b) a higher proportion of a given oral carbohydrate load tending to be directed to storage as glycogen rather than to oxidation, perhaps thereby diminishing the signals for food intake (31, 32) . In his paper, Flatt proposed that insulin resistance represents a mechanism which tends to limit further increase in adipase tissue mass (31) . Although insulin resistance, as we measured it using the euglycemic clamp, manifests as defects in both glucose oxidation and glucose storage, Felber et al. (33) have shown that under more physiological conditions, the defect in glucose oxidation is dominant. The higher glucose and insulin responses to oral glucose seen in insulin-resistant subjects overcomes the deficit in glucose storage, whereas the deficit in glucose oxidation remains.
We conclude that within this weight-gaining population of nondiabetic Pima Indians, insulin resistance is associated with a lower rate ofbody weight gain and, more specifically, it seems that low glucose oxidation secondary to weight gain may attenuate further weight gain.
